The phenomenon of antimicrobial resistance (AMR) is a critical global health challenge, with prospects indicating its potential to become the leading cause of death worldwide in the coming years. Individuals with pre-existing conditions, such as neoplastic disease undergoing chemotherapy, those on immunosuppressive therapy, and individuals with rare diseases like cystic fibrosis (CF), face heightened challenges due to AMR. CF is a rare disease caused by a deficiency in the synthesis of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) channel protein, resulting in multi-organ clinical symptoms, particularly in the respiratory system. PwCF experience recurrent pulmonary exacerbations triggered by bacterial or viral infections, making them particularly vulnerable to the impact of AMR. This review delves into the complex relationship between AMR and climate dynamics, focusing on the unique challenges faced by individuals with CF. It discusses the methods employed to measure AMR, its global impact on antibiotic resistance, and the specific microbial communities present in the CF airway. The review also explores the intricacies of antimicrobial resistance within the context of cystic fibrosis, emphasizing the urgent need for research in this field.

The Impact of Antimicrobial Resistance in Cystic Fibrosis / A. Vitiello, F. Blasi, M. Sabbatucci, A. Zovi, F. Miele, A. Ponzo, R. Langella, M. Boccellino. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2240-0109. - 13:6(2024), pp. 1711.1-1711.13. [10.3390/jcm13061711]

The Impact of Antimicrobial Resistance in Cystic Fibrosis

F. Blasi
Secondo
;
2024

Abstract

The phenomenon of antimicrobial resistance (AMR) is a critical global health challenge, with prospects indicating its potential to become the leading cause of death worldwide in the coming years. Individuals with pre-existing conditions, such as neoplastic disease undergoing chemotherapy, those on immunosuppressive therapy, and individuals with rare diseases like cystic fibrosis (CF), face heightened challenges due to AMR. CF is a rare disease caused by a deficiency in the synthesis of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) channel protein, resulting in multi-organ clinical symptoms, particularly in the respiratory system. PwCF experience recurrent pulmonary exacerbations triggered by bacterial or viral infections, making them particularly vulnerable to the impact of AMR. This review delves into the complex relationship between AMR and climate dynamics, focusing on the unique challenges faced by individuals with CF. It discusses the methods employed to measure AMR, its global impact on antibiotic resistance, and the specific microbial communities present in the CF airway. The review also explores the intricacies of antimicrobial resistance within the context of cystic fibrosis, emphasizing the urgent need for research in this field.
antimicrobial resistance (AMR); cystic fibrosis; pulmonary exacerbations; CFTR channel; microbial communities
Settore MED/10 - Malattie dell'Apparato Respiratorio
2024
Article (author)
File in questo prodotto:
File Dimensione Formato  
THE IMPACT OF ANTIMICROBIAL RESISTANCE I N CYSTIC FIBROSIS jOURNAL OF CLINICAL MEDICINE-2024.pdf

accesso aperto

Descrizione: Review
Tipologia: Publisher's version/PDF
Dimensione 723.57 kB
Formato Adobe PDF
723.57 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1039748
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact